JFG
MIRM icon

Jefferies Financial Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Jefferies Financial Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,800
Closed -$198K – 1639
2024
Q2 		$198K Sell
5,800
-4,200
-42% -$110K ﹤0.01% 1228
2024
Q1 		$251K Buy
+10,000
New +$275K ﹤0.01% 1271

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Jefferies Financial Group's MIRM Position: Q1 2026 in Review

Jefferies Financial Group opened a new position in Mirum Pharmaceuticals (MIRM) in Q1 2026: 8,500 shares worth $785K. The stake represents 0.01% of the portfolio and ranks #1016 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in MIRM as recently as Q1 2025.

Jefferies Financial Group first reported a position in MIRM in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.06M in Q1 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Jefferies Financial Group held 8,500 shares of Mirum Pharmaceuticals worth $785K as of Q1 2026.
  • Mirum Pharmaceuticals was a new Jefferies Financial Group position in Q1 2026.
  • Mirum Pharmaceuticals made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1016 holding.
  • Jefferies Financial Group first reported a position in Mirum Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • Jefferies Financial Group's Mirum Pharmaceuticals position peaked at $1.06M in Q1 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.